ストックスクリーナーアプリを入手
8.58
4.24%
-0.38
アフターアワーズ：
8.52
-0.06
-0.70%
前日終値:
$8.96
開ける：
$8.97
24時間の取引高:
5.32M
Relative Volume:
0.62
時価総額：
$2.94B
収益：
-
当期純損益:
$-75.80M
株価収益率:
-24.51
EPS:
-0.35
ネットキャッシュフロー:
$-68.07M
1週間 パフォーマンス:
-8.72%
1か月 パフォーマンス:
+14.86%
6か月 パフォーマンス:
+318.54%
1年 パフォーマンス:
+231.27%
1日の値動き範囲:
$8.27
$9.03
1週間の範囲:
$8.27
$9.435
52週間の値動き範囲:
$1.54
$9.75
Nuvation Bio Inc Stock (NUVB) Company Profile
名前
Nuvation Bio Inc
セクター
電話
(415) 754-3517
住所
357 TEHAMA STREET, FLOOR 3, SAN FRANCISCO
NUVB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NUVB
Nuvation Bio Inc
|
8.58 | 3.07B | 0 | -75.80M | -68.07M | -0.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.13 | 115.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.31 | 81.12B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.17 | 52.54B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
839.99 | 51.78B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.12 | 37.12B | 447.02M | -1.18B | -906.14M | -6.1812 |
Nuvation Bio Inc Stock (NUVB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-24 | 開始されました | Truist | Buy |
| 2025-11-19 | 開始されました | B. Riley Securities | Buy |
| 2025-09-30 | 開始されました | Jefferies | Buy |
| 2025-04-23 | 開始されました | Citizens JMP | Mkt Outperform |
| 2024-03-27 | アップグレード | Jefferies | Hold → Buy |
| 2024-03-26 | アップグレード | BTIG Research | Neutral → Buy |
| 2023-01-06 | ダウングレード | Jefferies | Buy → Hold |
| 2022-08-02 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2022-08-02 | ダウングレード | BTIG Research | Buy → Neutral |
| 2022-05-04 | 開始されました | H.C. Wainwright | Buy |
| 2021-10-15 | 再開されました | BTIG Research | Buy |
| 2021-04-06 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-03-08 | 開始されました | BMO Capital Markets | Outperform |
| 2021-03-08 | 開始されました | BTIG Research | Buy |
| 2021-03-08 | 開始されました | Cowen | Outperform |
| 2021-03-08 | 開始されました | Jefferies | Buy |
| 2021-03-08 | 開始されました | Wedbush | Outperform |
すべてを表示
Nuvation Bio Inc (NUVB) 最新ニュース
Nuvation Bio stock today: NUVB slides nearly 7% as early gains fade - ts2.tech
Nuvation Bio (NYSE:NUVB) Stock Price Down 5.4%Here's What Happened - MarketBeat
Nuvation Bio Inc. (NYSE:NUVB) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Published on: 2025-12-23 19:34:24 - bollywoodhelpline.com
Nuvation Bio (NUVB) upgraded to buy: Here's what you should know - MSN
Nuvation Bio Earnings Notes - Trefis
Why Nuvation Bio Inc. Warrants stock gets analyst attentionJuly 2025 Retail & Free Verified High Yield Trade Plans - Улправда
How Nuvation Bio Inc. Warrants stock responds to bond marketInflation Watch & Weekly Watchlist for Hot Stocks - Улправда
Trading Recap: Will Nuvation Bio Inc. stock outperform growth indexes2025 Market WrapUp & AI Based Buy/Sell Signal Reports - Улправда
How Nuvation Bio Inc. stock reacts to oil pricesProfit Target & Safe Swing Trade Setup Alerts - Bölüm Sonu Canavarı
Wall Street Analysts Believe Nuvation Bio (NUVB) Could Rally 25.14%: Here's is How to Trade - Yahoo Finance
Is Nuvation Bio Inc. stock positioned for long term growthTrade Ideas & Expert Approved Momentum Ideas - DonanımHaber
Why Nuvation Bio Inc. stock is trending among retail tradersQuarterly Earnings Report & Short-Term High Return Ideas - DonanımHaber
How Nuvation Bio Inc. stock reacts to bond yieldsMarket Movement Recap & Fast Gaining Stock Reports - DonanımHaber
Why Nuvation Bio Inc. Class stock could be next leaderJuly 2025 Outlook & Reliable Entry Point Alerts - DonanımHaber
Nuvation Bio (NYSE:NUVB) Reaches New 52-Week HighStill a Buy? - MarketBeat
Nuvation Bio stock hits 52-week high at 8.96 USD By Investing.com - Investing.com Canada
Nuvation Bio stock hits 52-week high at 8.96 USD - Investing.com
Will Nuvation Bio Inc. stock outperform growth indexesMarket Sentiment Summary & Entry Point Confirmation Alerts - Улправда
How buyback programs support Nuvation Bio Inc. Class stockJuly 2025 Momentum & Fast Exit/Entry Strategy Plans - Улправда
Nuvation Bio Sees Unusually Large Options Volume (NYSE:NUVB) - MarketBeat
Has Nuvation Bio’s 234% Surge in 2025 Already Reflected Its Growth Potential? - Yahoo Finance
Nuvation Bio (NUVB): Reassessing Valuation After a 78% Monthly Surge in the Share Price - Yahoo Finance
Is Nuvation Bio’s 228.6% 2025 Surge Still Supported by Valuation? - Sahm
Nuvation Bio (NUVB) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
FY2025 EPS Estimates for Nuvation Bio Boosted by Analyst - MarketBeat
Gap Down: How Nuvation Bio Inc stock reacts to oil prices2025 EndofYear Setup & High Conviction Buy Zone Picks - moha.gov.vn
Nuvation Bio Inc. $NUVB Shares Sold by OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat
Natixis Buys Shares of 905,500 Nuvation Bio Inc. $NUVB - MarketBeat
HC Wainwright & Co. maintains Nuvation Bio (NUVB) buy recommendation - MSN
Breakout Move: Why Nuvation Bio Inc stock is trending among retail tradersFed Meeting & Free Fast Entry Momentum Trade Alerts - moha.gov.vn
Nuvation Bio (NUVB) Soars After $18 Price-Target Hike – Is This High‑Growth Cancer Stock Still a Buy in 2025? - ts2.tech
Nuvation Bio (NYSE:NUVB) Shares Gap Up After Analyst Upgrade - MarketBeat
Nuvation Bio Stock Surges Amid Price Target Boost - TipRanks
HC Wainwright Issues Positive Forecast for Nuvation Bio (NYSE:NUVB) Stock Price - MarketBeat
Nuvation Bio stock price target raised to $18 from $10 at H.C. Wainwright By Investing.com - Investing.com South Africa
Nuvation Bio stock price target raised to $18 from $10 at H.C. Wainwright - Investing.com Nigeria
Institutional Investors in Nuvation Bio Inc. (NYSE:NUVB) Lost 6.3% Last Week but Have Reaped the Benefits of Longer-term Growth - 富途牛牛
HC Wainwright & Co. Maintains Nuvation Bio (NUVB) Buy Recommendation - Nasdaq
Nuvation Bio (NUVB): Reassessing Valuation After Safusidenib Data and Taletrectinib China Reimbursement News - Sahm
Nuvation Bio (NYSE:NUVB) Trading Down 5.9%Here's Why - MarketBeat
Nuvation Bio Inc. $NUVB is Omega Fund Management LLC's 4th Largest Position - MarketBeat
Nuvation Bio (NUVB) price target increased by 12.48% to 10.65 - MSN
Why Nuvation Bio (NUVB) Is Up 6.5% After Strong Safusidenib Phase 2 Glioma Data And What's Next - Sahm
Nuvation Bio (NYSE: NUVB) partner taletrectinib added to China's 2025 NRDL - Stock Titan
Nuvation Bio (NUVB) Price Target Increased by 12.48% to 10.65 - Nasdaq
Tema Etfs LLC Purchases Shares of 139,648 Nuvation Bio Inc. $NUVB - MarketBeat
Nuvation Bio Stock Jump Looks Great, But How Secure Is That Gain? - Trefis
Nuvation Bio (NUVB) bounces back 12% on impressive clinical trial result - MSN
Why Nuvation Bio Inc. Class stock is a strong analyst pickPortfolio Update Report & Verified Momentum Stock Alerts - Newser
Cash per share of Nuvation Bio Inc. – NYSE:NUVB - TradingView
Nuvation Bio Inc (NUVB) 財務データ
収益
当期純利益
現金流量
EPS
0.57%
大文字化:
|
ボリューム (24 時間):